ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2438

Effectiveness Of Exercise Program  in Ankylosing Spondylitis: Meta-Analysis Of Randomized Controlled Trials

Virginie Pécourneau1, Arnaud L. Constantin2 and Alain G. Cantagrel3, 1CHU Toulouse, Toulouse, France, 2Rheumatology, Purpan University Hospital, Toulouse Cedex 9, France, 3Dept of Rheumatology, Hopital Purpan, Toulouse CEDEX 9, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Exercise and physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Effectiveness of exercise programs in ankylosing spondylitis: meta-analysis of randomized controlled trials

Virginie Pécourneau1, Adeline Ruyssen-Witrand1, Thomas Barnetche2, Alain Cantagrel1, Arnaud Constantin1.

1 Centre de Rhumatologie, HÃxpital Purpan, 31059, Toulouse Cedex 9, France.

2 Service de Rhumatologie, HÃxpital Pellegrin Tripode, 33076, Bordeaux Cedex, France.

Disclosure : none.

Background/Purpose: Current recommendations for management of ankylosing spondylitis (AS) encompass appropriate medication and exercises as the cornerstones of treatment. The aim of our study is to assess the efficacy of exercise programs on disease activity and function in AS patients through a meta-analysis of randomized controlled trials.

Methods: A systematic literature search was performed on Medline and Cochrane databases up to February 2013. Randomized controlled trials examining the effectiveness of exercise programs for AS patients were included. Outcomes analyzed were evolution of BASDAI and BASFI after the completion of exercise programs. Modalities of exercise were compared and the use of biotherapy reported. Efficacy was assessed by weighted mean differences (WMDs) of exercise program versus control groups. Heterogeneity was assessed with Cochran’s Q-test and I2. Standardized mean differences (SMDs) were pooled through meta-analysis using the inverse variance model.

Results: After screening of 167 abstracts, a total of 23 trials were selected for detailed evaluation and 7 trials were finally included, assessing home based exercise programs (2/7), swimming (1/7), Pilates training (1/7) or supervised exercises (2/7), with a total of 275 AS patients. Two trials included patients with anti-TNF therapy. All trials except one showed a decrease of BASDAI and BASFI in exercise groups. The WMDs (95% CI) were -0.73 (-1.15, -0.30) (I²=4%, p=0.0007) for BASDAI and -0.73 (-1.22, -0.23) (I²= 2%, p=0.004) for BASFI in favor of exercise programs.

Conclusion: Even if the small numbers of patients and the quality of exercise programs constitute potential limitations of the randomized clinical trials included in this meta-analysis, its results support the potential of exercise programs to improve disease activity and function in AS.

Fig 1 — Meta-analysis of randomized controlled trials assessing the impact of exercise program on BASDAI in AS patients.

Fig 2 — Meta-analysis of randomized controlled trials assessing the impact of exercise program on BASFI in AS patients.


Disclosure:

V. Pécourneau,
None;

A. L. Constantin,
None;

A. G. Cantagrel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-exercise-program-in-ankylosing-spondylitis-meta-analysis-of-randomized-controlled-trials/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology